Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-01-30Clinical Trial Update: Gallium Ga 68 DOTA-NeoBOMB1 and Gallium Ga 68 PSMA-R2 PET/MRI in Diagnosing Participants With Recurrent Prostate Cancer [Phase 2]
Phase 2 trial update evaluating Gallium-68 DOTA-NeoBOMB1 and Gallium-68 PSMA-R2 PET/MRI for diagnosing recurrent prostate cancer with PSA pr…
-
CLINICAL_TRIALS trial_result · 2024-01-30Clinical Trial Update: Self-Administered Nitrous Oxide (SANO) During Transrectal Prostate Biopsy to Reduce Patient Anxiety and Pain [Phase 4]
Phase 4 trial evaluating self-administered nitrous oxide to reduce anxiety and pain during transrectal prostate biopsy; study completed with…
-
CLINICAL_TRIALS trial_result · 2024-01-30Clinical Trial Update: 68-Ga PSMA 11 PET/MRI and 68-Ga RM2 PET/MRI for Evaluation of Prostate Cancer Response to HIFU Therapy [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating 68-Ga PSMA-11 PET/MRI and 68-Ga RM2 PET/MRI for monitoring prostate cancer response to HIFU therapy; res…
-
CLINICAL_TRIALS trial_result · 2024-01-24Clinical Trial Update: The Metformin Active Surveillance Trial (MAST) Study [Phase 3]
A Phase 3 clinical trial update for the Metformin Active Surveillance Trial (MAST) in prostate cancer is reported with unknown status.
-
CLINICAL_TRIALS trial_result · 2024-01-24Clinical Trial Update: Radium-223 Combined With Dexamethasone as First-line Therapy in Patients With M+CRPC [Phase 4]
Phase 4 trial update investigating Radium-223 combined with dexamethasone as first-line therapy for metastatic castration-resistant prostate…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA label_change · 2024-01-23FDA Approved: VABRINTY — Supplemental Application (URONOVA PHARMACEUTICALS, INC.)
FDA approved a supplemental application for VABRINTY (leuprolide acetate) from Uronova Pharmaceuticals to modify the drug's labeling.
-
CLINICAL_TRIALS trial_result · 2024-01-19Clinical Trial Update: Prostate Advances in Comparative Evidence [Phase 3]
Phase 3 clinical trial update for prostate cancer within the Prostate Advances in Comparative Evidence program.
-
CLINICAL_TRIALS trial_result · 2024-01-17Clinical Trial Update: Nivolumab With or Without Ipilimumab in Advanced Metastatic Cancer [Phase 2]
Phase 2 trial assessing nivolumab with or without ipilimumab in advanced metastatic cancer, completed with results posted in 2024.
-
CLINICAL_TRIALS trial_result · 2024-01-16Clinical Trial Update: TAVT-45 (Abiraterone Acetate) Granules in Patients With Prostate Cancer [Phase 3]
Phase 3 trial update for TAVT-45 (Abiraterone Acetate) granules in metastatic prostate cancer patients has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2024-01-12Clinical Trial Update: Study to Compare the Effects of Repeated Doses of an Investigational New Drug and a Placebo on Appetite in Advanced Cancer and Anorexia [Phase 1]
Phase 1 study comparing repeated doses of an investigational drug versus placebo to assess effects on appetite in advanced cancer and anorex…
-
CLINICAL_TRIALS trial_result · 2024-01-11Clinical Trial Update: 68Ga PSMA 11 PET/MRI and 68Ga RM2 PET/MRI for Biopsy Guidance in Patients With Suspected Prostate Cancer [Phase 2]
Phase 2 trial update evaluating 68Ga PSMA-11 PET/MRI and 68Ga RM2 PET/MRI for biopsy guidance in suspected prostate cancer.
-
CLINICAL_TRIALS trial_result · 2024-01-11Clinical Trial Update: GTN Therapy on Biomarkers of Immune Escape in Men With Biochemical Recurrence of Prostate Cancer After Primary Therapy [Phase 2]
Phase 2 clinical trial update evaluating GTN therapy effects on biomarkers of immune escape in men with biochemical recurrence of prostate c…
-
CLINICAL_TRIALS trial_result · 2024-01-05Clinical Trial Update: Patient Preference of Apalutamide Versus Enzalutamide in Patients With Recurrent or Metastatic Hormone-Sensitive Prostate Cancer [Phase 3]
Phase 3 trial comparing patient preference between apalutamide and enzalutamide in recurrent or metastatic hormone-sensitive prostate cancer…
-
CLINICAL_TRIALS trial_result · 2024-01-05Clinical Trial Update: ARFI Imaging for Targeted Prostate Biopsy [NA]
Duke University-sponsored trial evaluating ARFI imaging for targeted prostate biopsy was terminated; results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-01-02Clinical Trial Update: Study of Histrelin Subdermal Implant in Patients With Prostate Cancer [Phase 3]
Phase 3 clinical trial investigating the histrelin subdermal implant in patients with prostate cancer has been completed.
-
CLINICAL_TRIALS trial_result · 2024-01-02Clinical Trial Update: Study to Evaluate Efficacy and Safety of Histrelin Subdermal Implant in Men With Advanced Prostate Cancer [Phase 3]
Phase 3 clinical trial evaluating histrelin subdermal implant for advanced prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2024-01-02Clinical Trial Update: Prothrombin Complex Concentrate vs Fresh Frozen Plasma in Goal-directed Bleeding Management in Non-cardiac Surgery [Phase 4]
Phase 4 clinical trial comparing Prothrombin Complex Concentrate with Fresh Frozen Plasma for goal-directed bleeding management in non-cardi…
-
CLINICAL_TRIALS trial_result · 2023-12-26Clinical Trial Update: Intermittent Darolutamide Treatment in the Triple Therapy of mHSPC [Phase 3]
Phase 3 clinical trial evaluating intermittent darolutamide treatment as part of triple therapy for metastatic hormone-sensitive prostate ca…
-
CLINICAL_TRIALS trial_result · 2023-12-20Clinical Trial Update: Study of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-641/KEYNOTE-641) [Phase 3]
Phase 3 trial evaluating pembrolizumab plus enzalutamide versus placebo plus enzalutamide in metastatic castration-resistant prostate cancer…
-
FDA approval · 2023-12-19FDA Approved: ERLEADA — Supplemental Application (Janssen Products, LP)
The FDA approved a supplemental application for ERLEADA (apalutamide) filed by Janssen Products, LP. The approval updates the drug's labelin…
-
CLINICAL_TRIALS trial_result · 2023-12-18Clinical Trial Update: A Parallel Arm Phase 1b/2a Study of DKN-01 as Monotherapy or in Combination With Docetaxel for the Treatment of Advanced Prostate Cancer With Elevated DKK1 [Phase 1, Phase 2]
Phase 1b/2a trial of DKN-01 as monotherapy or with docetaxel in advanced prostate cancer with elevated DKK1 was terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2023-12-15Clinical Trial Update: EVOLUTION: 177Lu-PSMA Therapy Versus 177Lu-PSMA in Combination With Ipilimumab and Nivolumab for Men With mCRPC [Phase 2]
Phase 2 clinical trial update comparing 177Lu-PSMA therapy alone versus 177Lu-PSMA with ipilimumab and nivolumab in men with metastatic cast…
-
CLINICAL_TRIALS trial_result · 2023-12-13Clinical Trial Update: Long-term Better Than Short-term ADT With Salvage RT [Phase 2, Phase 3]
A clinical trial update investigating long-term androgen deprivation therapy (ADT) with salvage radiotherapy for prostate cancer, currently …
-
CLINICAL_TRIALS trial_result · 2023-12-08Clinical Trial Update: Fluzoparib and Abiraterone in the preSurgery Treatment of Prostate Cancer: FAST Trial [Phase 2]
Phase 2 FAST trial evaluating fluzoparib and abiraterone as pre-surgery treatment for high-risk prostate cancer in a neoadjuvant setting.
-
CLINICAL_TRIALS trial_result · 2023-12-07Clinical Trial Update: PET Imaging in MCI Following ADT for PCa
A completed clinical trial evaluating PET imaging in individuals with mild cognitive impairment following androgen deprivation therapy for p…